Literature DB >> 11405953

Physician advice for smoking cessation.

C Silagy1, L F Stead.   

Abstract

BACKGROUND: Health care professionals frequently advise patients to improve their health by stopping smoking. Such advice may be brief, or part of more intensive interventions.
OBJECTIVES: The aims of this review were to assess the effectiveness of advice from physicians in promoting smoking cessation; to compare minimal interventions by physicians with more intensive interventions; to assess the effectiveness of various aids to advice in promoting smoking cessation and to determine the effect of anti-smoking advice on disease specific and all cause mortality. SEARCH STRATEGY: We searched the Cochrane Tobacco Addiction Group trials register and the Cochrane Controlled Trials Register. Date of the most recent searches: October 2000. SELECTION CRITERIA: Randomized trials of smoking cessation advice from a medical practitioner in which abstinence was assessed at least six months after advice was first provided. DATA COLLECTION AND ANALYSIS: We extracted data in duplicate on the setting in which advice was given, type of advice given (minimal or intensive), and whether aids to advice were used, the outcome measures, method of randomization and completeness of followup. The main outcome measures were abstinence from smoking after at least six months follow-up and mortality. We used the most rigorous definition of abstinence in each trial, and biochemically validated rates where available. Subjects lost to follow-up were counted as smokers. Where possible, meta-analysis was performed using a fixed effects model. MAIN
RESULTS: We identified thirty four trials, conducted between 1972 and 1999, including over 27,000 smokers. In some trials, subjects were at risk of specified diseases (chest disease, diabetes, ischaemic heart disease), but most were from unselected populations. The most common setting for delivery of advice was primary care. Other settings included hospital wards and outpatient clinics, and industrial clinics. Pooled data from 16 trials of brief advice versus no advice (or usual care) revealed a small but significant increase in the odds of quitting (odds ratio 1.69, 95% confidence interval 1.45 to 1.98). This equates to an absolute difference in the cessation rate of about 2.5%. There was insufficient evidence, from indirect comparisons, to establish a significant difference in the effectiveness of physician advice according to the intensity of the intervention, the amount of follow-up provided, and whether or not various aids were used at the time of the consultation in addition to providing advice. However, direct comparison of intensive versus minimal advice showed a small advantage of intensive advice (odds ratio 1.44, 95% confidence interval 1.23 to 1.68). Only one study determined the effect of smoking advice on mortality. It found no statistically significant differences in death rates at twenty years follow-up. REVIEWER'S
CONCLUSIONS: Simple advice has a small effect on cessation rates. Additional manoeuvres appear to have only a small effect, though more intensive interventions are marginally more effective than minimal interventions.

Entities:  

Mesh:

Year:  2001        PMID: 11405953     DOI: 10.1002/14651858.CD000165

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  20 in total

Review 1.  Medications for smoking cessation.

Authors:  Robin L Corelli; Karen Suchanek Hudmon
Journal:  West J Med       Date:  2002-03

2.  Clinical trial comparing nicotine replacement therapy (NRT) plus brief counselling, brief counselling alone, and minimal intervention on smoking cessation in hospital inpatients.

Authors:  A Molyneux; S Lewis; U Leivers; A Anderton; M Antoniak; A Brackenridge; F Nilsson; A McNeill; R West; J Moxham; J Britton
Journal:  Thorax       Date:  2003-06       Impact factor: 9.139

Review 3.  ABC of smoking cessation. Use of simple advice and behavioural support.

Authors:  Tim Coleman
Journal:  BMJ       Date:  2004-02-14

Review 4.  [Chronic bronchitis, COPD].

Authors:  H R Wirtz
Journal:  Internist (Berl)       Date:  2005-02       Impact factor: 0.743

5.  Health information seeking and media exposure among smokers: a comparison of light and intermittent tobacco users with heavy users.

Authors:  Lila J Finney Rutten; Erik M Augustson; Kelly A Doran; Richard P Moser; Bradford W Hesse
Journal:  Nicotine Tob Res       Date:  2009-03-05       Impact factor: 4.244

6.  Effectiveness of an Intervention to Teach Physicians How to Assist Patients to Quit Smoking in Argentina.

Authors:  Raul Mejia; Eliseo J Pérez Stable; Celia P Kaplan; Steven E Gregorich; Jennifer Livaudais-Toman; Lorena Peña; Mariela Alderete; Veronica Schoj; Ethel Alderete
Journal:  Nicotine Tob Res       Date:  2015-07-14       Impact factor: 4.244

7.  Smokers with airway obstruction are more likely to quit smoking.

Authors:  M Bednarek; D Gorecka; J Wielgomas; M Czajkowska-Malinowska; J Regula; G Mieszko-Filipczyk; M Jasionowicz; R Bijata-Bronisz; M Lempicka-Jastrzebska; M Czajkowski; G Przybylski; J Zielinski
Journal:  Thorax       Date:  2006-06-29       Impact factor: 9.139

8.  Impact of vital signs screening & clinician prompting on alcohol and tobacco screening and intervention rates: a pre-post intervention comparison.

Authors:  J Paul Seale; Sylvia Shellenberger; Mary M Velasquez; John M Boltri; Ike Okosun; Monique Guyinn; Dan Vinson; Monica Cornelius; J Aaron Johnson
Journal:  BMC Fam Pract       Date:  2010-03-05       Impact factor: 2.497

9.  Teaching patient-centered tobacco intervention to first-year medical students.

Authors:  Richard L Brown; Judie M Pfeifer; Craig L Gjerde; Christine S Seibert; Cynthia L Haq
Journal:  J Gen Intern Med       Date:  2004-05       Impact factor: 5.128

10.  Gender differences among hardcore smokers: an analysis of the tobacco use supplement of the current population survey.

Authors:  Erik M Augustson; Dilyara Barzani; Lila J Finney Rutten; Stephen Marcus
Journal:  J Womens Health (Larchmt)       Date:  2008-09       Impact factor: 2.681

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.